CanSino Biologics (HKSE:06185) Buildings And Improvements : HK$1,181.5 Mil (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is CanSino Biologics Buildings And Improvements?

CanSino Biologics's quarterly buildings and improvements stayed the same from Mar. 2024 (HK$0.0 Mil) to Jun. 2024 (HK$0.0 Mil) but then increased from Jun. 2024 (HK$0.0 Mil) to Dec. 2024 (HK$1,181.5 Mil).

CanSino Biologics's annual buildings and improvements increased from Dec. 2022 (HK$1,125.3 Mil) to Dec. 2023 (HK$1,394.5 Mil) but then declined from Dec. 2023 (HK$1,394.5 Mil) to Dec. 2024 (HK$1,181.5 Mil).

CanSino Biologics Buildings And Improvements Historical Data

The historical data trend for CanSino Biologics's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanSino Biologics Buildings And Improvements Chart

CanSino Biologics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buildings And Improvements

Get a 7-Day Free Trial

100.37

1,200.01

1,125.30

1,394.45

1,181.47

CanSino Biologics Quarterly Data
	Dec16	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24
Buildings And Improvements	Get a 7-Day Free Trial														-	1,394.45	-	-	1,181.47

CanSino Biologics Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

CanSino Biologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (HKSE:06185) » Definitions » Buildings And Improvements

Traded in Other Exchanges

CASBF:USA CJH:Germany 688185:China

Address

185 South Avenue, 401-420, 4th Floor, Biomedical Park, TEDA West District, Tianjin, CHN

Website

https://www.cansinotech.com

CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.

Executives

The Goldman Sachs Group, Inc.	2201 Interest of corporation controlled by you
Yu Xuefeng	2501 Other
Chao Shou Bai	2202 Interest of your spouse
Mao Helen Huihua	2201 Interest of corporation controlled by you
The Capital Group Companies, Inc.	2201 Interest of corporation controlled by you
Jpmorgan Chase & Co.
Citigroup Inc.
Blackrock, Inc.	2201 Interest of corporation controlled by you
Qiming Corporate Gp Iv, Ltd.	2201 Interest of corporation controlled by you
Qiming Gp Iv, L.p.	2201 Interest of corporation controlled by you
Qiming Venture Partners Iv, L.p.	2201 Interest of corporation controlled by you
Qm29 Limited	2101 Beneficial owner
Qiu Dongxu	2501 Other
Zhu Tao
Orbimed Capital Llc	2102 Investment manager

CanSino Biologics Headlines

No Headlines